Cargando…
Post-COVID-19 interstitial lung disease: Insights from a machine learning radiographic model
INTRODUCTION: Post-acute sequelae of COVID-19 seem to be an emerging global crisis. Machine learning radiographic models have great potential for meticulous evaluation of post-COVID-19 interstitial lung disease (ILD). METHODS: In this multicenter, retrospective study, we included consecutive patient...
Autores principales: | Karampitsakos, Theodoros, Sotiropoulou, Vasilina, Katsaras, Matthaios, Tsiri, Panagiota, Georgakopoulou, Vasiliki E., Papanikolaou, Ilias C., Bibaki, Eleni, Tomos, Ioannis, Lambiri, Irini, Papaioannou, Ourania, Zarkadi, Eirini, Antonakis, Emmanouil, Pandi, Aggeliki, Malakounidou, Elli, Sampsonas, Fotios, Makrodimitri, Sotiria, Chrysikos, Serafeim, Hillas, Georgios, Dimakou, Katerina, Tzanakis, Nikolaos, Sipsas, Nikolaos V., Antoniou, Katerina, Tzouvelekis, Argyris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9886681/ https://www.ncbi.nlm.nih.gov/pubmed/36733935 http://dx.doi.org/10.3389/fmed.2022.1083264 |
Ejemplares similares
-
Corrigendum: Post-COVID-19 interstitial lung disease: Insights from a machine learning radiographic model
por: Karampitsakos, Theodoros, et al.
Publicado: (2023) -
Clinical features and outcomes of patients with myositis associated-interstitial lung disease
por: Karampitsakos, Theodoros, et al.
Publicado: (2023) -
Tocilizumab improves 28-day survival in hospitalized patients with severe COVID-19: an open label, prospective study
por: Karampitsakos, Theodoros, et al.
Publicado: (2021) -
Tocilizumab versus baricitinib in hospitalized patients with severe COVID-19: an open label, randomized controlled trial
por: Karampitsakos, Theodoros, et al.
Publicado: (2023) -
High-Flow vs. Low-Flow Nasal Cannula in Reducing Hypoxemic Events During Bronchoscopic Procedures: A Systematic Review and Meta-Analysis
por: Sampsonas, Fotios, et al.
Publicado: (2022)